Effect of angiotensin-converting enzyme or vasopeptidase inhibition on ventricular size and function in patients with heart failure: The Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) echocardiographic. study

SD Solomon; H Skali; M Bourgoun; J Fang; JK Ghali; M Martelet; D Wojciechowski; B Ansmite; J Skards; T Laks; D Henry; M Packer; MA Pfeffer

doi:10.1016/j.ahj.2004.09.056

Effect of angiotensin-converting enzyme or vasopeptidase inhibition on ventricular size and function in patients with heart failure: The Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) echocardiographic. study

SD Solomon, H Skali, M Bourgoun, J Fang, JK Ghali, M Martelet, D Wojciechowski, B Ansmite, J Skards, T Laks, D Henry, M Packer, MA Pfeffer

Research output: Contribution to journal › Article › peer-review

42 Citations (Scopus)

Original language	English
Pages (from-to)	257-262
Journal	American Heart Journal
Volume	150
Issue number	2
DOIs	https://doi.org/10.1016/j.ahj.2004.09.056
Publication status	Published - Aug 2005
Externally published	Yes

Field of Science*

3.1 Basic medicine

Publication Type*

1.1. Scientific article indexed in Web of Science and/or Scopus database

Access to Document

10.1016/j.ahj.2004.09.056

https://www.sciencedirect.com/science/article/pii/S0002870305000359?via%3Dihub

Cite this

Solomon, SD., Skali, H., Bourgoun, M., Fang, J., Ghali, JK., Martelet, M., Wojciechowski, D., Ansmite, B., Skards, J., Laks, T., Henry, D., Packer, M., & Pfeffer, MA. (2005). Effect of angiotensin-converting enzyme or vasopeptidase inhibition on ventricular size and function in patients with heart failure: The Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) echocardiographic. study. American Heart Journal, 150(2), 257-262. https://doi.org/10.1016/j.ahj.2004.09.056

@article{0d761a0338aa4659acc0cd8e10b80831,

title = "Effect of angiotensin-converting enzyme or vasopeptidase inhibition on ventricular size and function in patients with heart failure: The Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) echocardiographic. study",

author = "SD Solomon and H Skali and M Bourgoun and J Fang and JK Ghali and M Martelet and D Wojciechowski and B Ansmite and J Skards and T Laks and D Henry and M Packer and MA Pfeffer",

year = "2005",

month = aug,

doi = "10.1016/j.ahj.2004.09.056",

language = "English",

volume = "150",

pages = "257--262",

journal = "American Heart Journal",

issn = "0002-8703",

publisher = "Elsevier Inc.",

number = "2",

}

Solomon, SD, Skali, H, Bourgoun, M, Fang, J, Ghali, JK, Martelet, M, Wojciechowski, D, Ansmite, B, Skards, J, Laks, T, Henry, D, Packer, M & Pfeffer, MA 2005, 'Effect of angiotensin-converting enzyme or vasopeptidase inhibition on ventricular size and function in patients with heart failure: The Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) echocardiographic. study', American Heart Journal, vol. 150, no. 2, pp. 257-262. https://doi.org/10.1016/j.ahj.2004.09.056

Effect of angiotensin-converting enzyme or vasopeptidase inhibition on ventricular size and function in patients with heart failure: The Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) echocardiographic. study. / Solomon, SD; Skali, H; Bourgoun, M et al.
In: American Heart Journal, Vol. 150, No. 2, 08.2005, p. 257-262.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Effect of angiotensin-converting enzyme or vasopeptidase inhibition on ventricular size and function in patients with heart failure: The Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) echocardiographic. study

AU - Solomon, SD

AU - Skali, H

AU - Bourgoun, M

AU - Fang, J

AU - Ghali, JK

AU - Martelet, M

AU - Wojciechowski, D

AU - Ansmite, B

AU - Skards, J

AU - Laks, T

AU - Henry, D

AU - Packer, M

AU - Pfeffer, MA

PY - 2005/8

Y1 - 2005/8

U2 - 10.1016/j.ahj.2004.09.056

DO - 10.1016/j.ahj.2004.09.056

M3 - Article

SN - 0002-8703

VL - 150

SP - 257

EP - 262

JO - American Heart Journal

JF - American Heart Journal

IS - 2

ER -

Solomon SD, Skali H, Bourgoun M, Fang J, Ghali JK, Martelet M et al. Effect of angiotensin-converting enzyme or vasopeptidase inhibition on ventricular size and function in patients with heart failure: The Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) echocardiographic. study. American Heart Journal. 2005 Aug;150(2):257-262. doi: 10.1016/j.ahj.2004.09.056